New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 21, 2014
08:05 EDTBSXBoston Scientific's Synergy stent system reports strong performance data
Boston Scientific reported positive three-year follow-up data for the EVOLVE clinical trial, comparing the safety and performance of the Synergy Everolimus-Eluting Bioabsorbable Polymer Platinum Chromium Coronary Stent System to the PROMUS Element Stent System. The primary clinical and angiographic endpoints of this non-inferiority study have already been published.
News For BSX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
07:38 EDTBSXBoston Scientific risk/reward favorable after trial ends, says Wells Fargo
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use